Header Logo

Connection

Shabir Madhi to CD59 Antigens

Back to Details
This is a "connection" page, showing publications Shabir Madhi has written about CD59 Antigens.
Shabir Madhi
Connection Strength
0,056
CD59 Antigens
  1. Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study. Sci Rep. 2024 03 04; 14(1):5365.
    View in: PubMed
    Score: 0,056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.